$522K EBITDA Consumable Medical Device Distributor in Houston

A U.S. distributor with exclusive rights to an FDA-cleared consumable medical device in regenerative medicine is now available. Quick Highlights: -Over 80% of quarterly sales from prior customers >75% gross margins, ~30% EBITDA margins, 35% SDE margin -$1.8M expected 2025 revenue ($1.7M in 2024) <10 hrs/week current owner involvement -Low customer concentration The sector is expanding at a double-digit CAGR, fueled by the aging U.S. population, natural health demand, and the growth of medspas. With no employed salesforce and minimal marketing in place, this is a defensible, cash-flowing platform primed for professionalization and growth by a hands-on operator. Sign the NDA and request CIM access here: company.legacyoutcomes.com